Le-Mantus Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 6.00 M
- Paid Up Capital ₹ 2.50 M
- Company Age 19 Year, 20 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 8.58 Cr
- Satisfied Charges ₹ 10.31 Cr
- Revenue Growth 2.60%
- Profit Growth -28.44%
- Ebitda -9.36%
- Net Worth 25.00%
- Total Assets -12.74%
About Le-Mantus Pharmaceuticals
Le-Mantus Pharmaceuticals Private Limited (LPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 24 January 2006 and has a history of 19 years. Its registered office is in Delhi, Delhi.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 6.00 M and a paid-up capital of Rs 2.50 M.
The company currently has active open charges totaling ₹8.58 Cr. The company has closed loans amounting to ₹10.31 Cr, as per Ministry of Corporate Affairs (MCA) records.
Annu Gupta, Asha Jain, and Ashutosh Gupta serve as directors at the Company.
Company Details
- Location Delhi, Delhi
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24233DL2006PTC145303
-
Company No.
145303
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
24 Jan 2006
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
What products or services does Le-Mantus Pharmaceuticals Private Limited offer?
Le-Mantus Pharmaceuticals Private Limited offers a wide range of products and services, including Animal Medicines & Health Care, Anthelmintics, Industrial Chemicals & Supplies, Disinfectant Chemicals, Nutraceuticals & Dietary Supplements, Vitamin Tablets & Capsules, Cardiovascular Drugs & Medication, Cardiac Drugs, Veterinary Medicines, Antibiotic Injection.
Who are the key members and board of directors at Le-Mantus Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Annu Gupta
|
Director | 07-Jul-2010 | Current |
|
Asha Jain
|
Director | 13-Jul-2017 | Current |
|
Ashutosh Gupta
|
Director | 07-Jul-2010 | Current |
Financial Performance of Le-Mantus Pharmaceuticals.
Le-Mantus Pharmaceuticals Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 2.6% increase. The company also saw a substantial fall in profitability, with a 28.44% decrease in profit. The company's net worth Soared by an impressive increase of 25%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Le-Mantus Pharmaceuticals?
In 2023, Le-Mantus Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Lemantus Industrial Infra Developers LlpAnnu Gupta and Ashutosh Gupta are mutual person
Charges (Loans)
₹85.76 M
₹103.08 M
Charges Breakdown by Lending Institutions
- Others : 8.58 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Jun 2024 | Others | ₹8.58 Cr | Open |
| 28 Jul 2018 | Others | ₹6.34 Cr | Satisfied |
| 07 Feb 2017 | Others | ₹2.52 Cr | Satisfied |
| 04 Oct 2012 | Hdfc Bank Limited | ₹9.50 M | Satisfied |
| 12 Nov 2011 | Punjab National Bank | ₹5.00 M | Satisfied |
How Many Employees Work at Le-Mantus Pharmaceuticals?
Unlock and access historical data on people associated with Le-Mantus Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Le-Mantus Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Le-Mantus Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
